{"id":99194,"date":"2014-01-07T03:44:18","date_gmt":"2014-01-07T08:44:18","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/this-engineered-salmon-could-double-world-production-should-you-fear-frankenfish.php"},"modified":"2014-01-07T03:44:18","modified_gmt":"2014-01-07T08:44:18","slug":"this-engineered-salmon-could-double-world-production-should-you-fear-frankenfish","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/this-engineered-salmon-could-double-world-production-should-you-fear-frankenfish.php","title":{"rendered":"This Engineered Salmon Could Double World Production: Should You Fear Frankenfish?"},"content":{"rendered":"<p><p>    Genetically modified Atlantic salmon, trout, tilapia, and    shrimp will soon be coming to a dinner plate near you. Photo:    Hans-Petter Fjeld, Creative Commons.  <\/p>\n<p>    If you thought the seafood section of your local grocery store    offered a refuge from genetic modification techniques commonly    used in agricultural crops, I have some bad news for you.  <\/p>\n<p>    AquaBounty Technologies, now owned by synthetic biology company    Intrexon (NYSE:    XON) , has    developed an engineered Atlantic salmon named AquAdvantage    Salmon that matures twice as fast as conventional salmon.    Aquaculture may not be on your investing radar, but the global    industry is valued at over $100 billion and is the fastest    growing segment of the worldwide food industry. Genome editing    technologies promise to expedite the growth further -- and they    will arrive sooner than you think. The U.S. Food and Drug    Administration is poised to approve the aquaculture company's    product for marketing next year, which would open the    regulatory door for engineered trout, tilapia, and shrimp being    developed by the two companies.  <\/p>\n<p>    You may not like the idea of altering the genetic code of more    complex organisms -- especially those that end up on your    dinner plate -- instead preferring the technology sticks to    simpler microorganisms being developed by synthetic biology    companies such as Amyris (NASDAQ: AMRS) and    Solazyme (NASDAQ:    SZYM) .    However, enhanced aquaculture technologies present impressive    growth opportunities and environmental advantages for investors    and consumers. Is the technology safe? Are the advantages real    and measurable? How long until biotech fish stare back at you    from your own dinner plate? Let's swim through the    possibilities.  <\/p>\n<p>    How do you safely make a biotech fish?    It's actually quite simple. AquaBounty introduced one gene from    a Pacific Chinook salmon into its AquAdvantage Salmon, or AAS,    to allow it to grow to full market size in half the time.    Despite the hastier maturity profile, AAS produce the same    amount of growth hormone as conventional salmon. A molecular    switch (called a \"promoter\") from an antifreeze protein gene    was also integrated into the fish genome, although AAS do not    produce antifreeze protein. Additionally, all AAS will be    sterile females; ensuring there will be no gene flow to wild    populations if they escape production facilities.  <\/p>\n<p>    Engineered fish will undoubtedly encounter some backlash from    consumers -- with Whole Foods Market already    stating it would ban them from its stores -- but the U.S. Food    and Drug Administration announced that they were safe to eat in    2010. Moreover, considering that Atlantic salmon hold roughly    40,000 genes -- compared to about 24,000 genes for humans --    only 0.0025% of the genome has been altered. Aside from growth,    there are no discernable differences between AquaBounty's    engineered product and a wild Atlantic salmon.  <\/p>\n<p>    Nonetheless, that single genetic change results in a giant gain    in productivity. It's important to note that AAS do not grow    larger than wild Atlantic salmon -- they simply grow to full    size more quickly. Take a look at how they compare to their    conventional counterparts:  <\/p>\n<p>    AAS will be harvested near the 550-day mark. Source: AquaBounty    Technologies.  <\/p>\n<p>    AquaBounty can grow the same amount of fish in half the time    (or less) while adding substantial environmental benefits with    no additional risks. But are the advantages tangible?  <\/p>\n<p>    Advantages of biotech fishAlthough    Intrexon played no role in developing AquAdvantage Salmon, the    companies are exploring ways to utilize synthetic biology to    develop even better products with more efficient production    profiles. If you think of traditional     genetic engineering -- crops and essentially all    genetically engineered commercial products created to date --    as the first, most basic form of genome editing, then synthetic    biology -- or utilizing the building blocks of life to assemble    novel technologies -- represents the     next big leap. Either way, both can offer real and    measurable advantages.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See original here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/rss.feedsportal.com\/c\/34518\/f\/631681\/s\/358746c2\/sc\/32\/l\/0L0Sfool0N0Cinvesting0Cgeneral0C20A140C0A10C0A50Cthis0Eengineered0Esalmon0Ecould0Edouble0Eworld0Eproducti0Baspx0Dsource0Fehesitrf0A0A0A0A0A0A1\/story01.htm\" title=\"This Engineered Salmon Could Double World Production: Should You Fear Frankenfish?\">This Engineered Salmon Could Double World Production: Should You Fear Frankenfish?<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Genetically modified Atlantic salmon, trout, tilapia, and shrimp will soon be coming to a dinner plate near you. Photo: Hans-Petter Fjeld, Creative Commons.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/this-engineered-salmon-could-double-world-production-should-you-fear-frankenfish.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-99194","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/99194"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=99194"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/99194\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=99194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=99194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=99194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}